Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $18.93M | 41,889,142 | 12.20% | 14.47% | Net Buying | |||
| KALA | KALA BIO INC | $9.23M | 6,452,398 | 6.83% | 93.17% | Net Selling | Net Selling | ||
| GOVX | GEOVAX LABS INC | $14.07M | 25,359,593 | 0.21% | 99.79% | Net Buying | Net Buying | ||
| MRSN | MERSANA THERAPEUTICS INC | $46.11M | 4,990,692 | 30.77% | 69.23% | Net Selling | Net Selling | ||
| FGEN | FIBROGEN INC | $42.66M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Selling | ||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $3.99M | 1,205,402 | 0.38% | 99.62% | Net Selling | |||
| ATYR | ATYR PHARMA INC | $94.34M | 89,004,436 | 74.54% | 17.28% | Net Buying | Net Buying | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $78.42M | 17,661,698 | 29.13% | 25.91% | ||||
| ACXP | ACURX PHARMACEUTICALS INC | $11.85M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| NRXP | NRX PHARMACEUTICALS INC | $62.47M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| SGMO | SANGAMO THERAPEUTICS INC | $202.75M | 301,709,485 | 16.98% | 10.74% | Net Selling | Net Selling | ||
| GRI | GRI BIO INC | $4.68M | 2,515,305 | 0.71% | 99.29% | ||||
| PSTV | PLUS THERAPEUTICS INC | $69.49M | 99,264,526 | 0.38% | 23.86% | Net Buying | Net Buying | ||
| FEMY | FEMASYS INC | $16.70M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.97M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| LSTA | LISATA THERAPEUTICS INC | $20.38M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| MDCX | MEDICUS PHARMA LTD | $44.18M | 17,816,266 | 11.79% | 55.54% | Net Buying | Net Buying | ||
| MTVA | METAVIA INC | $23.67M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| CING | CINGULATE INC | $22.25M | 5,412,523 | 3.75% | 96.25% | ||||
| ENLV | ENLIVEX THERAPEUTICS LTD | $27.44M | 23,858,301 | 10.74% | 60.23% | ||||
| SKYE | SKYE BIOSCIENCE INC | $53.61M | 30,988,420 | 2.80% | 97.20% | Net Selling | Net Selling | ||
| CRDL | CARDIOL THERAPEUTICS INC | $85.98M | 82,674,725 | 7.82% | 0.00% | ||||
| BOLT | BOLT BIOTHERAPEUTICS INC | $11.13M | 1,919,441 | 4.26% | 95.74% | Net Buying | |||
| SLN | SILENCE THERAPEUTICS PLC | $235.93M | 141,701,848 | 13.95% | 0.09% | ||||
| MBRX | MOLECULIN BIOTECH INC | $14.36M | 30,286,168 | 1.43% | 20.90% | Net Buying | |||
| JSPR | JASPER THERAPEUTICS INC | $39.01M | 16,253,332 | 20.42% | 79.58% | Net Buying | Net Buying | ||
| NOTE | FISCALNOTE HOLDINGS INC | $66.87M | 14,349,995 | 31.65% | 68.35% | Net Selling | Net Selling | ||
| ANVS | ANNOVIS BIO INC | $33.13M | 19,486,231 | 9.30% | 15.63% | Net Buying | Net Buying | ||
| IMUX | IMMUNIC INC | $86.14M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| VNRX | VOLITIONRX LTD | $49.49M | 107,595,421 | 22.29% | 35.36% | Net Buying | Net Buying | ||
| INTS | INTENSITY THERAPEUTICS INC | $14.35M | 47,057,727 | 4.20% | 4.44% | Net Buying | |||
| MYO | MYOMO INC | $40.83M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| PMN | PROMIS NEUROSCIENCES INC | $25.39M | 51,806,497 | 16.36% | 49.85% | Net Buying | Net Buying | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $12.90M | 2,611,788 | 0.26% | 99.74% | ||||
| PASG | PASSAGE BIO INC | $26.93M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Buying | ||
| RNXT | RENOVORX INC | $40.68M | 36,645,884 | 24.00% | 11.42% | Net Buying | Net Buying | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $272.91M | 221,881,029 | 70.14% | 29.86% | Net Selling | |||
| TIL | INSTIL BIO INC | $129.82M | 6,750,716 | 5.76% | 94.24% | Net Buying | Net Buying | ||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.61M | 5,726,750 | 0.16% | 99.84% | Net Buying | Net Selling | ||
| HUMA | HUMACYTE INC | $247.06M | 158,372,173 | 35.97% | 19.03% | Net Selling | Net Selling | ||
| BMEA | BIOMEA FUSION INC | $99.97M | 59,508,518 | 48.27% | 28.91% | Net Buying | |||
| ACET | ADICET BIO INC | $79.98M | 82,709,625 | 62.39% | 20.18% | Net Buying | Net Buying | ||
| CTSO | CYTOSORBENTS CORP | $57.35M | 62,610,376 | 26.26% | 45.19% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.